Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis. (Q54444161)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 March 2007

Language	Label	Description	Also known as
English	Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.	scientific article published on 29 March 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

Pseudomonas aeruginosa

0 references

Escherichia coli

1 reference

based on heuristic

inferred from title

Jos W. M. van der Meer

4

object named as

Jos W M van der Meer

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

author name string

Jacqueline Buijs

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

Anthonius S M Dofferhoff

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

Johan W Mouton

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

language of work or name

0 references

publication date

29 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

59

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

926-933

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Incidence and impact of organ dysfunctions associated with sepsis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

The microbiology and outcome of sepsis in Victoria, Australia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Aureomycin therapy in human brucellosis due to Brucella melitensis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Antibiotic-induced endotoxin release from bacteria and its clinical significance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

A new simple whole blood flow cytometry-based method for simultaneous identification of activated cells and quantitative evaluation of cytokines released during activation.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Antibiotic-induced release of endotoxin: a reappraisal

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Effects of Different Types and Combinations of Antimicrobial Agents on Endotoxin Release from Gram-negative Bacteria: An In-Vitro and In-Vivo Study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

The structure and function of Escherichia coli penicillin-binding protein 3.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Cefazolin and cephradine: Relationship between serum concentrations and tissue contents in mice

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Animal model pharmacokinetics and pharmacodynamics: a critical review

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

A comparison of antibiotic regimens in the treatment of acute melioidosis in a mouse model.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Continuous infusion of beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Does the dose matter?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Role of interleukin-6 in mortality from and physiologic response to sepsis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Modulation of macrophage responsiveness to lipopolysaccharide by IRAK-1 manipulation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM073

21 January 2018

Identifiers

10.1093/JAC/DKM073

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17395686

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54444161&oldid=2036040858"